Mitochondrial TXNRD3 confers drug resistance via redox-mediated mechanism and is a potential therapeutic target in vivo

Alterations in ROS metabolism and redox signaling are often observed in cancer cells and play a significant role in tumor development and drug resistance. However, the mechanisms by which redox alterations impact cellular sensitivity to anticancer drugs remain elusive. Here we have identified the mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaoxia, Zhang, Yanyu, Lu, Wenhua, Han, Yi, Yang, Jing, Jiang, Weiye, You, Xin, Luo, Yao, Wen, Shijun, Hu, Yumin, Huang, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397405/
https://www.ncbi.nlm.nih.gov/pubmed/32750669
http://dx.doi.org/10.1016/j.redox.2020.101652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397405/
https://www.ncbi.nlm.nih.gov/pubmed/32750669
http://dx.doi.org/10.1016/j.redox.2020.101652

Ejemplares similares